Journalartikel

Biotransformation of ciprofloxacin by Xylaria longipes: structure elucidation and residual antibacterial activity of metabolites.


AutorenlisteRusch, Marina; Spielmeyer, Astrid; Zorn, Holger; Hamscher, Gerd

Jahr der Veröffentlichung2018

Seiten8573-8584

ZeitschriftApplied Microbiology and Biotechnology

Bandnummer102

Heftnummer19

ISSN1432-0614

DOI Linkhttps://doi.org/10.1007/s00253-018-9231-y

VerlagSpringer


Abstract
The impressive ability of the fungus Xylaria longipes to transform the highly persistent fluoroquinolone ciprofloxacin into microbiologically less active degradation products was demonstrated. Fluoroquinolones are used extensively in both human and veterinary medicine. Poor metabolization and high chemical stability of these synthetic antibiotics led to their presence in several environmental compartments. This undesirable behavior may promote the spread of resistance mechanisms due to concomitant exposure to bacteria. Therefore, the biotransformation of ciprofloxacin, one of the most prescribed fluoroquinolones in human medicine, by the ascomycetous soft rot fungus X. longipes was investigated in detail. Submerged cultivation of the fungus allowed for high-yield formation of four biotransformation products. These compounds were subsequently purified by preparative high-performance liquid chromatography. Applying accurate mass spectrometry and nuclear magnetic resonance spectroscopy, desethylene-ciprofloxacin, desethylene-N-acetyl-ciprofloxacin, N-formyl-ciprofloxacin and N-acetyl-ciprofloxacin were unambiguously identified. N-acetylation and N-formylation of the drug led to a 75-88% reduction of the initial antibacterial activity, whereas a breakdown of the piperazine substituent resulted in almost inactive products. These findings suggest an important role in the inactivation and degradation of this and other synthetic compounds in the environment.



Zitierstile

Harvard-ZitierstilRusch, M., Spielmeyer, A., Zorn, H. and Hamscher, G. (2018) Biotransformation of ciprofloxacin by Xylaria longipes: structure elucidation and residual antibacterial activity of metabolites., Applied Microbiology and Biotechnology, 102(19), pp. 8573-8584. https://doi.org/10.1007/s00253-018-9231-y

APA-ZitierstilRusch, M., Spielmeyer, A., Zorn, H., & Hamscher, G. (2018). Biotransformation of ciprofloxacin by Xylaria longipes: structure elucidation and residual antibacterial activity of metabolites.. Applied Microbiology and Biotechnology. 102(19), 8573-8584. https://doi.org/10.1007/s00253-018-9231-y


Zuletzt aktualisiert 2025-21-05 um 14:39